| |
 |
|
Class Information
Number: 514/319
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms > Piperidines > Additional ring containing > The additional ring is one of the cyclos in a polycyclo ring system
Description: Subject matter wherein the additional ring is one of the cyclos in a polycyclo ring system.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7615557 |
Tetrahydro-naphthalene and urea derivatives |
Nov. 10, 2009 |
| 7612096 |
Methods for treatment, modification and management of radiculopathy using 1-oxo-2-(2,6-dioxopiperidin-3yl)-4-aminoisoindoline |
Nov. 3, 2009 |
| 7598271 |
Crystalline paroxetine methane sulfonate |
Oct. 6, 2009 |
| 7582653 |
Mercaptophenyl naphthyl methane compounds and synthesis thereof |
Sep. 1, 2009 |
| 7576103 |
Tetralin and indane derivatives and uses thereof |
Aug. 18, 2009 |
| 7572787 |
Substituted naphthalene sulfonamides |
Aug. 11, 2009 |
| 7569586 |
Compounds having .beta..sub.2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
Aug. 4, 2009 |
| 7569587 |
Antibacterial mutilins |
Aug. 4, 2009 |
| 7563810 |
Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases |
Jul. 21, 2009 |
| 7563808 |
Methods for treating cognitive impairments or dementia |
Jul. 21, 2009 |
| 7550485 |
Substituted N-heterocycle derivatives and methods of their use |
Jun. 23, 2009 |
| 7531535 |
Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
May. 12, 2009 |
| 7528153 |
Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors |
May. 5, 2009 |
| 7507753 |
Biaryl compound and use thereof |
Mar. 24, 2009 |
| 7501441 |
Naphthyl compounds, intermediates, processes, compositions, and methods |
Mar. 10, 2009 |
| 7432284 |
Estrogen receptor modulators |
Oct. 7, 2008 |
| 7429602 |
Treating conjunctivitis by topically administering an epinastine solution to the conjunctiva |
Sep. 30, 2008 |
| 7405222 |
Methods and compositions for treatment of erectile dysfunction |
Jul. 29, 2008 |
| 7378447 |
Muscarinic agonists |
May. 27, 2008 |
| 7368462 |
Melanin concentrating hormone antagonists |
May. 6, 2008 |
| 7326716 |
Treatment of inflammatory bowel disease |
Feb. 5, 2008 |
| 7312222 |
Heterocyclic piperidines as modulators of chemokine receptor activity |
Dec. 25, 2007 |
| 7307078 |
Polycyclic compounds which modulate PPAR.gamma. type receptors and cosmetic/pharmaceutical compositions comprised thereof |
Dec. 11, 2007 |
| 7304065 |
Melanin concentrating hormone antagonists |
Dec. 4, 2007 |
| 7276491 |
Anticoagulant and fibrinolytic therapy using p38 MAP kinase inhibitors |
Oct. 2, 2007 |
| 7265132 |
Compounds useful as reversible inhibitors of cysteine proteases |
Sep. 4, 2007 |
| 7238683 |
Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
Jul. 3, 2007 |
| 7217706 |
Propanolamine derivatives |
May. 15, 2007 |
| 7214692 |
Medical use for tachykinin antagonists |
May. 8, 2007 |
| 7211589 |
Atisane compounds and use thereof |
May. 1, 2007 |
| 7208488 |
N-substituted benzene sulfonamides |
Apr. 24, 2007 |
| 7205294 |
Selected CGRP-antagonists process for preparing them and their use as pharmaceutical compositions |
Apr. 17, 2007 |
| 7189740 |
Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes |
Mar. 13, 2007 |
| 7153868 |
N-(3-(4-substituted-1-piperidinyl)-1-phenylpropyl) substituted sulfonamides as NK-3 receptor antagonists |
Dec. 26, 2006 |
| 7144898 |
Indole derivatives for the treatment of depression and anxiety |
Dec. 5, 2006 |
| 7125869 |
Polycyclic compounds which modulate PPAR.gamma. type receptors and cosmetic/pharmaceutical compositions comprised thereof |
Oct. 24, 2006 |
| 7125880 |
Corticotropin releasing factor antagonists |
Oct. 24, 2006 |
| 7125887 |
Pyrrolidine modulators of CCR5 chemokine receptor activity |
Oct. 24, 2006 |
| 7115633 |
Benzosuberonylpiperdine compounds as analgesics |
Oct. 3, 2006 |
| 7109214 |
Substituted cyclopentene compounds |
Sep. 19, 2006 |
| 7105541 |
Naphthyl compounds, intermediates, compositions, and methods of use |
Sep. 12, 2006 |
| 7105540 |
Cholinesterase inhibitors to treat disorders of attention |
Sep. 12, 2006 |
| 7090853 |
Noscapine derivatives as adjuvant compositions and methods of use thereof |
Aug. 15, 2006 |
| 7091218 |
4-substituted piperidine compound |
Aug. 15, 2006 |
| 7087622 |
Pyridone compounds as inhibitors of bacterial type III protein secreation systems |
Aug. 8, 2006 |
| 7087599 |
Estrogen receptor modulators |
Aug. 8, 2006 |
| 7084140 |
Arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
Aug. 1, 2006 |
| 7081465 |
Alpha-substituted naphthyloxy omega-substituted alky/aryl amino-substituted alkane derivatives as agent for treatment or prophylaxis of diabetes and related metabolic disorders |
Jul. 25, 2006 |
| 7064136 |
Compounds |
Jun. 20, 2006 |
| 7064124 |
NF-.kappa.B inhibitor containing substituted benzoic acid derivative as active ingredient |
Jun. 20, 2006 |
|
|
|
